Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • Photobucket

  • FDA Registered Contract Manufacturer

CardiAQ Technologies (Irvine, CA), a developmental-stage medical device company focused on percutaneous mitral heart valve replacement, closed a $37.3M Series B financing. Participants include OrbiMed, Versant Ventures, Advent Life Sciences and Broadview Advisors.

TriReme Medical (Pleasanton, CA), a commercial-stage medical device company focused on percutaneous devices for the treatment of coronary and peripheral arterial disease, closed an $18M Series E financing. Participants include Luminor Capital.

Endosense (Switzerland), a commercial-stage medical device company focused on catheter ablation for cardiac arrhythmias, closed a $40.3M Series C financing. Participants included NGN Capital, Edmond de Rothschild Investment Partners, NeoMed Management, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

Cibiem (New York, NY), a development-stage medical device company focused on sympathetic nervous system-mediated diseases, closed a $10M Series A financing. Participants include SV Life Sciences and Third Rock Ventures. Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem Request Collective IP Account [...]

Vascular Magnetics (Philadelphia, PA) a development-stage medical device focused on magnetically targeted drug delivery for the treatment of peripheral artery disease, closed a $7M Series A financing. Participants include Devon Park Bioventures. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up.

CardioInsight Technologies (Cleveland, OH) a commercial-stage medical device company focused on non-invasive electrocardiographic mapping technology, closed a $7.5 Series C financing. Participants were not disclosed.

BiO2 Medical (San Antonio, TX) a clinical-stage medical device company focused on catheters for pulmonary embolism in critical care patients, closed a $13.7M Series B financing. Participants include Incyte Capital and Pasadera Capital.

Avinger (Redwood City, CA) a commercial-stage medical device company focused on optical coherence tomography imaging catheters for the treatment of Peripheral Artery Disease, closed a $22.5M Series C financing. Participants were not identified.

Atlanta Catheter Therapies (Chattanooga, TN) a development-stage medical device company focused on catheter technologies for vascular disease, closed a $2.9M Series A financing. Participants were not identified.

CV Ingenuity (Palo Alto, CA) a development-stage medical device company focused on vascular obstructions, closed a $16M Series B financing. Participants include New Enterprise Associates, BioStar Ventures, Synergy Ventures and Western Technology.

CircuLite (Saddle Brook, NJ) a clinical-stage medical device company focused on minimally invasive implantable devices for chronic heart failure, closed a $30M Series D financing. Participants include Forbion Capital Partners and MacAndrews & Forbes Holdings.

Acutus Medical (San Diego, CA) a development-stage medical device company focused on electrophysiological mapping technology for the treatment of cardiac arrhythmias, closed a $1M Series A financing. Participants include Index Ventures. Thanx for your patience as we catch-up.

Acutus Medical (San Diego, CA) a development-stage medical device company focused on electrophysiological mapping for the treatment of cardiac arrhythmias, closed a $1M Series A financing. Participants include Index Ventures.

« Previous Entries  Next Page »

to top of page...